|
|
| Neurologie > Etude de marché sectorielle |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
25 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Insight: Cognitive Impairment in Schizoaffective Disorder - Inevitable or Treatable?
259 pages | Octobre 2005 |
IntroductionCognitive impairment is regarded as a core deficit of schizophrenia; the primary unmet need is the availability of an effective drug for the treatment of cognitive impairment in schizophre |
12 920,00 €
|
| |
| |
Pipeline and Commercial Insight: Alzheimer's Disease - Beta treatments on the horizon
272 pages | Novembre 2005 |
IntroductionAlzheimer's patients remain poorly treated and are growing in number.
Currently, cholinesterase inhibitors and the more recent NMDA-receptor antagonists provide only moderate and tempor |
19 380,00 €
|
| |
| |
World Sleep Disorders Market, 2004-2011
1 pages | Mars 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pipeline Insight: Anxiety Disorders - A decade of declining revenues
310 pages | Mars 2006 |
IntroductionThe global anxiety disorders market is set to decline from $4.5 billion in 2006 to $2.6 billion by 2015 (CAGR 200615 -6.0%).
This will be primarily due to the launch of numerous generic |
9 120,00 €
|
| |
| |
Neurological Monitors Market, 1998-2008
1 pages | Mai 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
MarketWatch: CNS
28 pages | Juillet 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: CNS
25 pages | Janvier 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
New Drugs in Development for Alzheimer's Disease
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
MarketWatch: CNS
29 pages | Mars 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: CNS
30 pages | Avril 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.
|
|
In this month’s MarketWatch…
This month's highlights
Page 2 - Key Announcements
Page 2 - CNS News Round-Up
Neurology
Page 4 - Opinion: Schwarz: lacosamide on track for dual approval…
Page 5 - Headlines
Page 5 - Alzheimer's Disease Update
Page 6 - Multiple Sclerosis Update
Page 7 - Parkinson's Disease Update
Psychiatry
Page 9 - Headlines
Page 9 - Depression Update
Page 11 - Behavioral Disorders Update
Pain
Page 13 - Headlines
Page 13 - R&D Update
Page 15 - Regulatory Update
Page 16 - Licensing & Collaborations Update
Company Spotlight
Page 18 - Forest Laboratories
Further Reading
Page 23
Index
Page 24 - Pharma companies
Page 24 - Biotech companies
Page 25 - Key Drugs
|
|
|
PPLSEN
|
|
|
|
|
